Biosceptre

About:

Biosceptre has identified a cancer target, nf-P2X7, present in many cancer types, and importantly not found in healthy tissue.

Website: http://biosceptre.com

Top Investors: Norcliffe Capital, Jungle Capital, Tuspark Science and Technology Service Group, Mark Gillespie, Bluesky Partnership II L.P

Description:

Biosceptre is driving innovation to bring new and progressive therapies to a wide range of cancer patients. Our focus is a multiple-targeted universal CAR T system with the potential to improve the lives of millions of patients across the world who are suffering from a wide range of malignancies.